Evidence map›Paper›PMID 36838719›Full record

ReviewMolecules (Basel, Switzerland)2023

Phenolic Compounds from New Natural Sources-Plant Genotype and Ontogenetic Variation.

Renata Nurzyńska-Wierdak

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
7.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Sweet Woodruff (Molecules (Basel, Switzerland) · 2026
    Review
  7. Review
  8. Seasonal Dynamics of Leaf Phenolic Compounds inPlants (Basel, Switzerland) · 2026
    Article
  9. Article
  10. Review
  11. Phytochemical Composition and Bioactivity ofPharmaceuticals (Basel, Switzerland) · 2026
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Renata Nurzyńska-WierdakDepartment of Vegetable and Herb Crops, Faculty of Horticulture and Landscape Architecture, University of Life Sciences in Lublin, Doświadczalna 50a, 20-280 Lublin, Poland.ORCID 0000-0002-9373-4841
University of Life Sciences in Lublin · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phenolic compounds (PCs) are widespread secondary metabolites with potent biological activity. Their sources are mainly plants from cultivated and natural states, providing valuable protective and health-promoting extracts. The wide biological activity of PCs (antioxidant, anti-inflammatory, antimicrobial, antiatherosclerotic, antidiabetic, antiallergic, prebiotic, antimutagenic) means that new sources of PCs are constantly being sought, as exemplified by extracting these compounds from tissue culture or agricultural by-products. Plant phenols show marked qualitative and quantitative variation not only at different genetic levels (between and within species and clones) but also between different physiological and developmental stages. Assessing genetic and seasonal variations in phenolic content and activity allows for selecting the best time to harvest the plant. Learning about the causes of PCs' variability and putting this knowledge into practice can significantly increase PCs' yields and extract the most valuable compounds. The health-promoting properties resulting from consuming products rich in plant PCs are undeniable, so it is worth promoting high-phenolic products as a regular diet. This paper presents an overview of different sources of PCs for use as potential therapeutic alternatives. Additionally, factors of variation in the phenolic complex at the genome and ontogeny levels, relevant in practical terms and as a basis for further scientific research, are presented.

Indexed as

PhenolsPlant ExtractsAntioxidantsGenotypePlantsAntioxidantsPhenolsPlant Extractsantioxidant activityplant developmentsecondary metabolitestherapeutic effectvariability factors

Identifiers

PMID36838719
PMCPMC9959341
OpenAlexW4320494386

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.